The Israeli Health ministry approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children aged 5 to 11, two weeks after the U.S. FDA grants its own approval, with vaccination expected to begin next week.
The Israeli Health ministry approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children 5 to 11, two weeks after the U.S. FDA grants its own approval, with vaccination expected to begin next week.
The Israeli Health ministry approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children aged5 to 11, two weeks after the U.S. FDA grants its own approval, with vaccination expected to begin next week.